EVOK insider transactions
Evoke Pharma Inc. (EVOK) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for EVOK
- Large owner Nantahala Capital Management, Llc disposed of $1,629,683 worth of shares (148,153 units at $11.00) (SEC Form 4)4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Pyszczymuka Greg4 - Evoke Pharma Inc (0001403708) (Issuer)
- Chief Medical Officer Carlson Marilyn R. closing all direct ownership in the company (SEC Form 4)4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Smeal Benjamin C.4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Garner Cam L4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Reed Vickie S4 - Evoke Pharma Inc (0001403708) (Issuer)
- Director Brady Todd C closing all direct ownership in the company (SEC Form 4)4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Widder Kenneth J4 - Evoke Pharma Inc (0001403708) (Issuer)
- Chief Executive Officer D'Onofrio Matthew J closing all direct ownership in the company (SEC Form 4)4 - Evoke Pharma Inc (0001403708) (Issuer)
- Chief Financial Officer Kowieski Mark closing all direct ownership in the company (SEC Form 4)4 - Evoke Pharma Inc (0001403708) (Issuer)
- Director Hill Malcolm R closing all direct ownership in the company (SEC Form 4)4 - Evoke Pharma Inc (0001403708) (Issuer)
- Large owner Klein Roger M. sold $95,885 worth of shares (9,000 units at $10.65) (SEC Form 4)4 - Evoke Pharma Inc (0001403708) (Issuer)
- New insider Klein Roger M. claimed ownership of 163,000 shares (SEC Form 3)3 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Hill Malcolm R4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Brady Todd C4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Garner Cam L4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Smeal Benjamin C.4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Pyszczymuka Greg4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Reed Vickie S4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Widder Kenneth J4 - Evoke Pharma Inc (0001403708) (Issuer)
- Chief Executive Officer D'Onofrio Matthew J was granted 1,000 shares, increasing direct ownership by 11% to 9,820 units (SEC Form 4)4 - Evoke Pharma Inc (0001403708) (Issuer)
- Chief Financial Officer Kowieski Mark was granted 4,500 shares, increasing direct ownership by 1,082% to 4,916 units (SEC Form 4)4 - Evoke Pharma Inc (0001403708) (Issuer)
- Chief Executive Officer D'Onofrio Matthew J was granted 6,849 shares, increasing direct ownership by 347% to 8,820 units (SEC Form 4)4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Pyszczymuka Greg4 - Evoke Pharma Inc (0001403708) (Issuer)
- New insider Pyszczymuka Greg claimed no ownership of stock in the company (SEC Form 3)3 - Evoke Pharma Inc (0001403708) (Issuer)
- Large owner Nantahala Capital Management, Llc sold $180 worth of shares (41 units at $4.39) (SEC Form 4)4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Chief Executive Officer D'Onofrio Matthew J4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Reed Vickie S4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Widder Kenneth J4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Brady Todd C4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Garner Cam L4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Hill Malcolm R4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Kowieski Mark4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Carlson Marilyn R.4 - Evoke Pharma Inc (0001403708) (Issuer)
- New insider Nantahala Capital Management, Llc claimed ownership of 148,194 shares (SEC Form 3)3 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Director Smeal Benjamin C.4 - Evoke Pharma Inc (0001403708) (Issuer)
- New insider Smeal Benjamin C. claimed no ownership of stock in the company (SEC Form 3)3 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Kowieski Mark4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Carlson Marilyn R.4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Chief Executive Officer D'Onofrio Matthew J4 - Evoke Pharma Inc (0001403708) (Issuer)
- New insider Kowieski Mark claimed ownership of 5,000 shares (SEC Form 3)3 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Hill Malcolm R4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Garner Cam L4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Reed Vickie S4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Widder Kenneth J4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Brady Todd C4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Widder Kenneth J4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Reed Vickie S4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Hill Malcolm R4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Garner Cam L4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Brady Todd C4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Gonyer David A4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by D'Onofrio Matthew J4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Carlson Marilyn R.4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Widder Kenneth J4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Reed Vickie S4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Hill Malcolm R4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Garner Cam L4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Brady Todd C4 - Evoke Pharma Inc (0001403708) (Issuer)
- SEC Form 4 filed by Gonyer David A4 - Evoke Pharma Inc (0001403708) (Issuer)